| 000 | 01575 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513210354.0 | ||
| 264 | 0 | _c20000626 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a0946-1965 | ||
| 024 | 7 |
_a10.5414/cpp38204 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchuldes, H | |
| 245 | 0 | 0 |
_aCytostatic sensitivity and MDR in bladder carcinoma cells: implications for tumor therapy. _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacology and therapeutics _cApr 2000 |
||
| 300 |
_a204-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
| 650 | 0 | 4 |
_aCarcinoma, Transitional Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
| 650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Resistance, Multiple |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aElectron Spin Resonance Spectroscopy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aVerapamil _xanalogs & derivatives |
| 700 | 1 | _aDolderer, J H | |
| 700 | 1 | _aSchoch, C | |
| 700 | 1 | _aBickeböller, R | |
| 700 | 1 | _aWoodcock, B G | |
| 773 | 0 |
_tInternational journal of clinical pharmacology and therapeutics _gvol. 38 _gno. 4 _gp. 204-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5414/cpp38204 _zAvailable from publisher's website |
| 999 |
_c10736761 _d10736761 |
||